NASDAQ:ITUS - ITUS Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous Close$4.64Today's Range$4.61 - $4.7652-Week Range$1.83 - $6.43Volume69,859 shsAverage Volume134,373 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email ITUS Corporation develops, acquires, and licenses emerging technologies in the areas of biotechnology. The company develops Cchek, a platform for non-invasive blood tests for the early detection of various cancers, including breast, lung, colon, melanoma, ovarian, liver, thyroid, pancreatic, appendiceal, uterine, osteosarcoma, leiomyosarcoma, liposarcoma, vulvar, and prostate cancer. It also develops immuno-therapy drugs for the treatment of cancer. The company was formerly known as CopyTele, Inc. and changed its name to ITUS Corporation in September 2014. ITUS Corporation was founded in 1982 and is based in San Jose, California. Receive ITUS News and Ratings via Email Sign-up to receive the latest news and ratings for ITUS and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Patent owners & lessors Sub-IndustryN/A SectorBusiness Services Current SymbolNASDAQ:ITUS Previous Symbol CUSIPN/A CIK715446 Webwww.ituscorp.com Phone408-708-9808Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable ITUS (NASDAQ:ITUS) Frequently Asked Questions What is ITUS's stock symbol? ITUS trades on the NASDAQ under the ticker symbol "ITUS." How were ITUS's earnings last quarter? ITUS Corp (NASDAQ:ITUS) announced its quarterly earnings results on Friday, March, 9th. The business services provider reported ($0.11) EPS for the quarter. View ITUS's Earnings History. Has ITUS been receiving favorable news coverage? News articles about ITUS stock have trended somewhat negative recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. ITUS earned a media sentiment score of -1.1 on InfoTrie's scale. They also assigned news coverage about the business services provider a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the next few days. Who are some of ITUS's key competitors? Some companies that are related to ITUS include Fortel (ECGP), Liberty Tax (TAX), Micro Imaging Technology (MMTC), RPX (RPXC) and Walker Innovation (WLKR). What other stocks do shareholders of ITUS own? Based on aggregate information from My MarketBeat watchlists, some companies that other ITUS investors own include Synergy Pharmaceuticals (SGYP), Micron Technology (MU), Progenics Pharmaceuticals (PGNX), ImmunoGen (IMGN), Advanced Micro Devices (AMD), NVIDIA (NVDA), Coherus Biosciences (CHRS), Global Blood Therapeutics (GBT), Galectin Therapeutics (GALT) and Vanda Pharmaceuticals (VNDA). Who are ITUS's key executives? ITUS's management team includes the folowing people: Dr. Amit Kumar Ph.D., Exec. Chairman, Pres & CEO (Age 54)Mr. Michael J. Catelani, COO, CFO & Corp. Sec. (Age 51)Mr. John Roop, Sr. VP of Engineering (Age 68)Mr. Anthony Campisi, VP of Engineering How do I buy shares of ITUS? Shares of ITUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is ITUS's official website? The official website for ITUS is http://www.ituscorp.com. How can I contact ITUS? ITUS's mailing address is 3150 ALMADEN EXPRESSWAY SUITE 250, SAN JOSE CA, 95118. The business services provider can be reached via phone at 408-708-9808 or via email at [email protected] MarketBeat Community Rating for ITUS (NASDAQ ITUS)Community Ranking: 2.0 out of 5 ( )Outperform Votes: 81 (Vote Outperform)Underperform Votes: 122 (Vote Underperform)Total Votes: 203MarketBeat's community ratings are surveys of what our community members think about ITUS and other stocks. Vote "Outperform" if you believe ITUS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ITUS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/25/2019 by MarketBeat.com StaffFeatured Article: What are municipal bonds?